Tags

Type your tag names separated by a space and hit enter

Independent and incremental value of ventilation/perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study.
Eur J Nucl Med Mol Imaging 2019; 46(8):1596-1604EJ

Abstract

PURPOSE

This pilot study assessed the independent and incremental value of 68Ga-V/Q PET/CT as compared with CT pulmonary angiography (CTPA) for the management of cancer patients with suspected acute pulmonary embolism (PE).

METHODS

All 24 cancer patients with suspected acute PE prospectively recruited underwent both 68Ga-V/Q PET/CT and CTPA within 24 h. PET/CT was acquired after inhalation of Galligas prepared using a Technegas generator and administration of 68Ga-macroaggregated albumin. Initially, PET/CT and CTPA scans were read independently with the reader blinded to the results of the other imaging study. CTPA and PET/CT were then coregistered and reviewed by consensus between a radiologist and nuclear medicine physician. The therapeutic management was established by the managing physician based on all available data.

RESULTS

The diagnostic conclusion was concordantly negative in 18 patients (75%). Of the six discordant diagnoses on independent reading, combined interpretation of V/Q PET/CTPA enabled a consensus conclusion in two patients, excluding PE in one and confirming PE in the other, similar to the initial diagnostic conclusion of the V/Q PET/CT. Of the remaining four patients, three had a single subsegmental thrombus on CTPA but a negative V/Q PET/CT scan, and two of these did not receive long-term anticoagulation and did not have a venous thromboembolic event during a 3-year follow-up period. The third patient, along with a patient with a positive V/Q PET/CT scan but a negative CTPA scan, presented with acute complications preventing any conclusions with regard to the appropriateness of the V/Q PET/CT results in the management of PE. Overall, V/Q PET had an impact on management in four patients (17%).

CONCLUSION

In this pilot study, we demonstrated the feasibility and potential utility of V/Q PET/CT for the management of patients with suspected PE. V/Q PET/CT may be of particular relevance in patients with equivocal findings or isolated subsegmental findings on CTPA, adding further discriminatory information to allow important decision-making regarding the use or withholding of anticoagulation. Given the other advantages of V/Q PET/CT (reduced acquisition time, low radiation dose), and with the increasing availability of 68Ga generators, PET/CT is a potential replacement for V/Q SPECT/CT imaging.

Authors+Show Affiliations

Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia. pierre-yves.leroux@chu-brest.fr. Nuclear Medicine, Brest University Hospital, EA3878 (GETBO) IFR 148, Brest, France. pierre-yves.leroux@chu-brest.fr.Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.Respiratory Medicine, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.Nuclear Medicine, Brest University Hospital, EA3878 (GETBO) IFR 148, Brest, France.Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia. Michael.hofman@petermac.org. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Michael.hofman@petermac.org.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31044265

Citation

Le Roux, Pierre-Yves, et al. "Independent and Incremental Value of Ventilation/perfusion PET/CT and CT Pulmonary Angiography for Pulmonary Embolism Diagnosis: Results of the PECAN Pilot Study." European Journal of Nuclear Medicine and Molecular Imaging, vol. 46, no. 8, 2019, pp. 1596-1604.
Le Roux PY, Iravani A, Callahan J, et al. Independent and incremental value of ventilation/perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study. Eur J Nucl Med Mol Imaging. 2019;46(8):1596-1604.
Le Roux, P. Y., Iravani, A., Callahan, J., Burbury, K., Eu, P., Steinfort, D. P., ... Hofman, M. S. (2019). Independent and incremental value of ventilation/perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study. European Journal of Nuclear Medicine and Molecular Imaging, 46(8), pp. 1596-1604. doi:10.1007/s00259-019-04338-z.
Le Roux PY, et al. Independent and Incremental Value of Ventilation/perfusion PET/CT and CT Pulmonary Angiography for Pulmonary Embolism Diagnosis: Results of the PECAN Pilot Study. Eur J Nucl Med Mol Imaging. 2019;46(8):1596-1604. PubMed PMID: 31044265.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Independent and incremental value of ventilation/perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study. AU - Le Roux,Pierre-Yves, AU - Iravani,Amir, AU - Callahan,Jason, AU - Burbury,Kate, AU - Eu,Peter, AU - Steinfort,Daniel P, AU - Lau,Eddie, AU - Woon,Beverly, AU - Salaun,Pierre-Yves, AU - Hicks,Rodney J, AU - Hofman,Michael S, Y1 - 2019/05/01/ PY - 2019/02/28/received PY - 2019/04/15/accepted PY - 2019/5/3/pubmed PY - 2019/5/3/medline PY - 2019/5/3/entrez KW - CT pulmonary angiography KW - Gallium-68 KW - Pulmonary embolism KW - V/Q PET/CT SP - 1596 EP - 1604 JF - European journal of nuclear medicine and molecular imaging JO - Eur. J. Nucl. Med. Mol. Imaging VL - 46 IS - 8 N2 - PURPOSE: This pilot study assessed the independent and incremental value of 68Ga-V/Q PET/CT as compared with CT pulmonary angiography (CTPA) for the management of cancer patients with suspected acute pulmonary embolism (PE). METHODS: All 24 cancer patients with suspected acute PE prospectively recruited underwent both 68Ga-V/Q PET/CT and CTPA within 24 h. PET/CT was acquired after inhalation of Galligas prepared using a Technegas generator and administration of 68Ga-macroaggregated albumin. Initially, PET/CT and CTPA scans were read independently with the reader blinded to the results of the other imaging study. CTPA and PET/CT were then coregistered and reviewed by consensus between a radiologist and nuclear medicine physician. The therapeutic management was established by the managing physician based on all available data. RESULTS: The diagnostic conclusion was concordantly negative in 18 patients (75%). Of the six discordant diagnoses on independent reading, combined interpretation of V/Q PET/CTPA enabled a consensus conclusion in two patients, excluding PE in one and confirming PE in the other, similar to the initial diagnostic conclusion of the V/Q PET/CT. Of the remaining four patients, three had a single subsegmental thrombus on CTPA but a negative V/Q PET/CT scan, and two of these did not receive long-term anticoagulation and did not have a venous thromboembolic event during a 3-year follow-up period. The third patient, along with a patient with a positive V/Q PET/CT scan but a negative CTPA scan, presented with acute complications preventing any conclusions with regard to the appropriateness of the V/Q PET/CT results in the management of PE. Overall, V/Q PET had an impact on management in four patients (17%). CONCLUSION: In this pilot study, we demonstrated the feasibility and potential utility of V/Q PET/CT for the management of patients with suspected PE. V/Q PET/CT may be of particular relevance in patients with equivocal findings or isolated subsegmental findings on CTPA, adding further discriminatory information to allow important decision-making regarding the use or withholding of anticoagulation. Given the other advantages of V/Q PET/CT (reduced acquisition time, low radiation dose), and with the increasing availability of 68Ga generators, PET/CT is a potential replacement for V/Q SPECT/CT imaging. SN - 1619-7089 UR - https://www.unboundmedicine.com/medline/citation/31044265/Independent_and_incremental_value_of_ventilation/perfusion_PET/CT_and_CT_pulmonary_angiography_for_pulmonary_embolism_diagnosis:_results_of_the_PECAN_pilot_study_ L2 - https://dx.doi.org/10.1007/s00259-019-04338-z DB - PRIME DP - Unbound Medicine ER -